Rosalind Advisors, Inc.
Institutional manager — quarterly 13F holdings, Q ending 2026-03-31
Reported value
$248.9M
Q ending 2026-03-31
Prior quarter
$284.5M
Q ending 2025-12-31
Change
-12.5% QoQ · +21.0% YoY
Positions
38
reported holdings
Largest positions
All 38 reported positions, Q ending 2026-03-31. A manager can hold shares, calls and puts on the same security at once — such positions are listed as separate rows. Type: Shares = common stock, Put/Call = option positions (valued at the underlying), Principal = debt. Tickers link to stock pages where covered.
| Holding | Ticker | Type | Value ▼ | Shares |
|---|---|---|---|---|
| Delcath Systems, Inc. | DCTH | Shares | $30.6M | 3.3M |
| Xeris Biopharma Holdings Inc | XERS | Shares | $18.7M | 3.2M |
| Fennec Pharmaceuticals Inc | FENC | Shares | $17.9M | 2.9M |
| Savara Inc | SVRA | Shares | $17.5M | 3.2M |
| Vaxcyte Inc | PCVX | Shares | $16.9M | 290K |
| Eyepoint Pharmaceuticals Inc | EYPT | Shares | $13.4M | 1.0M |
| X4 Pharmaceuticals Inc | XFOR | Shares | $13.3M | 3.2M |
| Vor Biopharma Inc | VOR | Shares | $12.5M | 700K |
| Mediwound Ltd | Shares | $12.1M | 749K | |
| Verastem Inc | VSTM | Shares | $11.3M | 2.1M |
| Celldex Therapeutics Inc | CLDX | Shares | $10.5M | 330K |
| Biocryst Pharmaceuticals Inc | BCRX | Shares | $8.8M | 923K |
| Cybin Inc | HELP | Shares | $7.4M | 1.5M |
| Cg Oncology Inc | CGON | Shares | $6.8M | 100K |
| Inspiremd Inc | NSPR | Shares | $6.4M | 3.9M |
| Atea Pharmaceuticals Inc | AVIR | Shares | $6.3M | 1.2M |
| Profound Medical Corp | PROF | Shares | $5.4M | 828K |
| Viridian Therapeutics Inc | VRDN | Shares | $4.9M | 250K |
| Replimune Group Inc | Call | $2.7M | 1.3M | |
| Polypid Ltd | Shares | $2.6M | 598K | |
| Myomo Inc | MYO | Shares | $2.6M | 3.8M |
| Talphera Inc | TLPH | Shares | $2.5M | 3.4M |
| Ovid Therapeutics Inc | OVID | Shares | $2.5M | 1.1M |
| Definium Therapeutics Inc | DFTX | Shares | $2.4M | 125K |
| Onkure Therapeutics Inc | OKUR | Shares | $1.8M | 444K |
| Lipocine Inc | LPCN | Shares | $1.8M | 222K |
| Neuraxis Inc | NRXS | Shares | $1.7M | 286K |
| Avalo Therapeutics Inc | AVTX | Shares | $1.1M | 75K |
| Annexon Inc | ANNX | Shares | $1.1M | 200K |
| Invesco Qqq Tr | Put | $1.1M | 250K | |
| Aquestive Therapeutics Inc | AQST | Shares | $1.0M | 250K |
| Spdr S&P 500 Etf Tr | Put | $959K | 125K | |
| Biofrontera Inc | BFRI | Shares | $942K | 1.2M |
| Kura Oncology Inc | KURA | Shares | $813K | 100K |
| Regentis Biomaterials Ltd | Shares | $768K | 252K | |
| Viridian Therapeutics Inc | Put | $53K | 264K | |
| Arrivent Biopharma Inc | Call | $0 | 109K | |
| Uniqure Nv | Call | $0 | 296K |
Values as reported in public regulatory filings (USD); holdings are reported quarterly, up to 45 days after quarter end, and may contain reporting errors. Nothing here is investment advice.